Browse by Condition in Sandpoint
Recruiting Clinical Trials in Sandpoint
NCT06524544 · Phase 3 · National Cancer Institute (NCI)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
NCT06649812 · Phase 2 · National Cancer Institute (NCI)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
NCT06917911 · Phase 2 · National Cancer Institute (NCI)
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
NCT07437950 · Phase 2 · National Cancer Institute (NCI)
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
NCT07393555 · Phase 2 · SWOG Cancer Research Network
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
NCT06948084 · Phase 2 · National Cancer Institute (NCI)
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
NCT07504588 · Phase 2 · National Cancer Institute (NCI)
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
Top Study Sponsors in Sandpoint
| Sponsor | Recruiting studies |
|---|---|
| National Cancer Institute (NCI) | 6 |
| SWOG Cancer Research Network | 1 |
Trials in Sandpoint by Phase
| Phase | Studies |
|---|---|
| Phase 2 | 6 |
| Phase 3 | 1 |
Clinical Trials in Sandpoint: Common Questions
How many clinical trials are recruiting in Sandpoint, ID?
7 clinical trials list a recruiting site in Sandpoint, ID, across 4 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Sandpoint?
The most active research areas in Sandpoint right now are leukemia, bladder cancer, lymphoma. Browse by condition above to see each study.
Who sponsors clinical trials in Sandpoint?
The sponsors with the most recruiting studies in Sandpoint include National Cancer Institute (NCI), SWOG Cancer Research Network.
Are there clinical trials for healthy volunteers in Sandpoint?
None of the recruiting studies in Sandpoint currently list healthy volunteers as eligible. New studies are added daily.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Sandpoint, ID
Sandpoint, ID is home to 7 actively recruiting clinical trials across 4 medical conditions as of 2026. The most active research areas include leukemia, bladder cancer, lymphoma. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.